[1]
G. Ghezzi, L. Ibba, L. Gargiulo, A. Narcisi, A. Costanzo, and M. Valenti, “Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience”, Dermatol Reports, Nov. 2024.